READY-2-GO
NEURONAL MITOCHONDRIAL HEALTH
ASSAY SERVICE
Measure mitochondrial location and function in human, iPSC-derived, glutamatergic neurons.
MITOCHONDRIAL DYSFUNCTION: A HALLMARK OF MANY NEURODEGENERATIVE DISEASES
Assessing mitochondrial health in early-stage drug development is proving crucial in understanding drug candidates' impact on the broader, cell-health continuum. As mitochondrial malfunction is increasingly implicated in the onset of neuronal dysfunction/death in diseases such as Alzheimer’s, Parkinson’s, and dementia, efforts in developing drugs that mitigate these effects are expanding.
Our Ready-2-Go Assay Service provides multiplexed measurements of mitochondrial quantity, location, and functionality using human, iPSC-derived, glutamatergic neurons.
KEY FEATURES
Uses human, iPSC-derived neurons
Multiplexed measurements of mitochondrial location and function
Only 6-8 weeks from assay to report
Option to bundle R2G Services or transition to Custom Services
ASSESS YOUR THERAPEUTICS' EFFECT ON MITOCHONDRIAL HEALTH
Human, iPSC-derived, glutamatergic neurons are treated with reference compounds alongside your test articles. Images are then acquired and analyzed at various time points to assess changes in mitochondrial location and membrane potential.
AVOID SPECIES DIFFERENCES WITH HUMAN, iPSC-DERIVED NEURONS
The use of animal models or immortalized cell lines limits clinical translatability. We use human, iPSC-glutamatergic neurons to help bridge the gap between the bench and clinic.
RELATED READY-2-GO SERVICES
Browse related Ready-2-Go assay offerings. For custom assays, check out our Custom Services.
R2G NEUROTOXICITY
Multiplexed readouts of viability and apoptosis.
Learn more
R2G NEURITE OUTGROWTH & NEURITE NETWORK DYNAMICS
Quantification of neurite outgrowth and changes in established neurite networks using human, iPSC-derived neurons.
Learn more
R2G MICROGLIA PHAGOCYTOSIS
Measure uptake of a fluorescent bacterial bioparticle by human, iPSC-derived microglia.
Learn more